Harrell Investment Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-17,296
Closed -$1.25M – 133
2025
Q1
$1.25M Buy
17,296
+5,811
+51% +$416K 0.37% 56
2024
Q4
$850K Sell
11,485
-12,378
-52% -$866K 0.24% 67
2024
Q3
$1.57M Sell
23,863
-877
-4% -$63.7K 0.45% 61
2024
Q2
$2.29M Sell
24,740
-83
-0.3% -$7.35K 0.66% 50
2024
Q1
$2.37M Buy
24,823
+699
+3% +$58.7K 0.7% 48
2023
Q4
$1.84M Sell
24,124
-4,008
-14% -$279K 0.57% 52
2023
Q3
$1.95M Buy
28,132
+1,747
+7% +$140K 0.66% 48
2023
Q2
$2.49M Sell
26,385
-670
-2% -$58.2K 0.84% 43
2023
Q1
$2.23M Buy
27,055
+2,524
+10% +$198K 0.79% 47
2022
Q4
$1.83M Sell
24,531
-4,717
-16% -$364K 0.72% 46
2022
Q3
$2.42M Buy
29,248
+1,972
+7% +$190K 1.01% 34
2022
Q2
$2.59M Buy
27,276
+797
+3% +$82.5K 1.06% 35
2022
Q1
$3.12M Buy
26,479
+2,101
+9% +$236K 1.1% 31
2021
Q4
$3.16M Buy
24,378
+2,438
+11% +$284K 0.97% 35
2021
Q3
$2.48M Buy
21,940
+5,133
+31% +$586K 0.8% 45
2021
Q2
$1.74M Buy
16,807
+2,185
+15% +$206K 0.56% 55
2021
Q1
$1.22M Sell
14,622
-1,072
-7% -$90.6K 0.43% 62
2020
Q4
$1.43M Sell
15,694
-1,071
-6% -$88.8K 0.55% 57
2020
Q3
$1.34M Buy
+16,765
New +$1.31M 0.58% 54

Other funds holding EW

Harrell Investment Partners's EW Position: Q2 2025 in Review

Harrell Investment Partners sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 17,296 shares — an estimated $1.25M sold.

Harrell Investment Partners first reported a position in EW in Q3 2020 and held it in 19 quarters. The position peaked at $3.16M in Q4 2021. 1,261 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Harrell Investment Partners reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Harrell Investment Partners sold 17,296 Edwards Lifesciences shares in Q2 2025, an estimated $1.25M.
  • Harrell Investment Partners first reported a position in Edwards Lifesciences in Q3 2020 and held it in 19 quarters.
  • Harrell Investment Partners's Edwards Lifesciences position peaked at $3.16M in Q4 2021.
  • 1,261 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Harrell Investment Partners's 13F filing for Q2 2025, filed 15 Jul 2025.